STOCK TITAN

Si-Bone Stock Price, News & Analysis

SIBN Nasdaq

Welcome to our dedicated page for Si-Bone news (Ticker: SIBN), a resource for investors and traders seeking the latest updates and insights on Si-Bone stock.

Si-Bone, Inc. (SIBN) is a leader in minimally invasive surgical solutions for sacroiliac joint disorders, pioneering orthopedic innovations since its founding. This news hub provides investors and healthcare professionals with essential updates on the company's progress in medical device development and market expansion.

Comprehensive SIBN Coverage: Access official press releases and third-party analysis covering regulatory milestones, quarterly earnings, product launches (including iFuse System updates), clinical trial results, and strategic partnerships. Our curated feed eliminates speculation to deliver actionable information about this NASDAQ-listed innovator.

Strategic Insights: Track SIBN's advancements in sacroiliac joint fusion technology alongside broader industry trends in orthopedic devices. Discover how patented titanium implants and FDA-cleared systems position the company within competitive medical sectors.

Bookmark this page for real-time updates on SIBN's financial performance, surgical innovation developments, and leadership in addressing underdiagnosed pelvic health conditions through clinically validated solutions.

Rhea-AI Summary

SI-BONE, Inc. reported financial results for the first quarter of 2024, showing worldwide revenue of $37.9 million, a 16% growth from the prior year. The company's U.S. revenue also increased by 16%, with a gross margin of 79%. SI-BONE is optimistic about revenue growth acceleration, driven by new product launches and market expansion. The company updated its 2024 revenue guidance to $164 million - $166 million, indicating a growth of 18% - 20%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.29%
Tags
-
Rhea-AI Summary

SI-BONE, a medical device company dedicated to musculoskeletal disorders, will be presenting at the 2024 BofA Securities Healthcare Conference. Investors can join the fireside chat on May 14, 2024, at 2:20 p.m. Eastern Time. The webcast will be accessible for replay for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.06%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags

FAQ

What is the current stock price of Si-Bone (SIBN)?

The current stock price of Si-Bone (SIBN) is $16.39 as of June 20, 2025.

What is the market cap of Si-Bone (SIBN)?

The market cap of Si-Bone (SIBN) is approximately 778.1M.
Si-Bone

Nasdaq:SIBN

SIBN Rankings

SIBN Stock Data

778.14M
37.84M
3.09%
95.51%
2.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA